Food and Drug Administration Safety and Innovation Act
Became Public Law No: 112-144.
SAMDT 2125 - 112
SAMDT 2125 - 112
To ensure that adequate information is disseminated to health care providers and payors about the potential benefits and risks of medical products on all patient populations, particularly underrepresented subpopulations, including racial subgroups.
Latest action
May 23, 2012
0
actions
0
cosponsors
1
bills
0
text versions
Connected bills
Timeline
No amendment action timeline is currently available.
Cosponsors
No amendment cosponsor records are currently available.
Text Versions
No amendment text versions are currently available.
Compiled amendment record. Amendment pages combine Congress.gov source payloads, normalized relationships, action timelines, text links, and search metadata. This is not an official government record.